Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 12, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 13, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001104659-26-015323
Filed / recorded
Feb 13, 2026, 10:01 PM UTC
Added to OQRO
Oct 8, 2026, 12:54 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Orchestra BioMed Holdings, Inc.
Issuer CIK
1814114
Ticker
OBIO
Reporting person
Darren Sherman
Relationship
Director, Officer
Officer title
See Remarks
Security
Common Stock, par value $0.0001 per share
Table
Non-derivative (Table I)
Transaction date
Feb 12, 2026
Transaction code
A
Shares / units
397,000
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
1,237,569
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 25% of the shares will vest 18 months after February 12, 2026 (the "Issue Date"), (ii) 25% of the shares will vest 24 months after the Issue Date, (iii) 25% of the shares will vest 30 months after the Issue Date and (iv) 25% of the shares will vest 36 months after the Issue Date, subject to the Reporting Person's continuous service through such dates.
2 tracked managers disclosed the same change for Q4 2025. From a 13F filed Feb 17, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.